Envestnet Asset Management
AMRX icon

Envestnet Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Envestnet Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.87M Buy
396,954
+82,681
+26% +$1.13M ﹤0.01% 2227
2026
Q1 		$3.91M Buy
314,273
+78,958
+34% +$1.06M ﹤0.01% 2512
2025
Q4 		$2.96M Buy
235,315
+74,705
+47% +$855K ﹤0.01% 2541
2025
Q3 		$1.61M Buy
+160,610
New +$1.44M ﹤0.01% 3022
2024
Q2 		– Sell
-41,050
Closed -$249K – 4167
2024
Q1 		$249K Sell
41,050
-159
-0.4% -$897 ﹤0.01% 3828
2023
Q4 		$250K Buy
41,209
+12,723
+45% +$56.7K ﹤0.01% 3713
2023
Q3 		$120K Buy
+28,486
New +$106K ﹤0.01% 3845
2022
Q3 		– Sell
-20,295
Closed -$65K – 3900
2022
Q2 		$65K Sell
20,295
-7,453
-27% -$27K ﹤0.01% 3794
2022
Q1 		$116K Buy
27,748
+278
+1% +$1.23K ﹤0.01% 3784
2021
Q4 		$132K Buy
27,470
+16,790
+157% +$83.7K ﹤0.01% 3732
2021
Q3 		$57K Sell
10,680
-746
-7% -$3.76K ﹤0.01% 3630
2021
Q2 		$59K Buy
11,426
+1,042
+10% +$5.92K ﹤0.01% 3595
2021
Q1 		$70K Sell
10,384
-15
-0.1% -$83 ﹤0.01% 3440
2020
Q4 		$48K Sell
10,399
-872
-8% -$3.86K ﹤0.01% 3229
2020
Q3 		$44K Buy
+11,271
New +$48.2K ﹤0.01% 3064
2019
Q2 		– Sell
-55,268
Closed -$783K – 3024
2019
Q1 		$783K Buy
55,268
+8,679
+19% +$115K ﹤0.01% 2043
2018
Q4 		$630K Buy
+46,589
New +$840K ﹤0.01% 2011
2018
Q3 		– Sell
-9,177
Closed -$151K – 1297
2018
Q2 		$151K Buy
+9,177
New +$161K ﹤0.01% 1803

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Envestnet Asset Management's AMRX Position: Q2 2026 in Review

Envestnet Asset Management increased its Amneal Pharmaceuticals (AMRX) stake by 26% in Q2 2026, buying an estimated $1.13M and bringing the position to 396,954 shares worth $6.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

Envestnet Asset Management first reported a position in AMRX in Q2 2018 and has held it in 18 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Envestnet Asset Management held 396,954 shares of Amneal Pharmaceuticals worth $6.87M as of Q2 2026.
  • Envestnet Asset Management bought 82,681 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2227 holding.
  • Envestnet Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 18 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.